IDEXX Laboratories has elected Joseph L. (Jay) Hooley to its Board of Directors, effective July 10, 2025. Hooley brings extensive strategic thinking and financial leadership experience from his tenure leading State Street during a period of global growth and technological transformation. He is an accomplished executive with public company board and corporate governance experience, complementing the skills of IDEXX's other Board members.
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has elected Joseph L. (Jay) Hooley to its Board of Directors, effective July 10, 2025. Hooley brings extensive strategic thinking and financial leadership experience from his tenure leading State Street during a period of global growth and technological transformation. He is an accomplished executive with public company board and corporate governance experience, complementing the skills of IDEXX's other Board members [1].
Lawrence D. Kingsley, the Company's Independent Non-Executive Board Chair, stated, "We are excited to welcome Jay to the IDEXX Board of Directors. Jay is an accomplished executive who brings extensive strategic thinking and financial leadership experience, along with investor perspective, from his tenure leading State Street during a period of global growth and technological transformation. Given his substantial public company board and corporate governance experience and his unique background and skills, which complement those of our other Board members, we are confident Jay will provide valuable insights that will contribute to our Board’s overall effectiveness."
Hooley, who served as the Chair and CEO of State Street Corporation from 2011 to 2019, and as the CEO from 2010 to 2018, is currently the lead independent director on the board of directors of Exxon Mobil Corporation and Aptiv PLC. He received his bachelor’s degree from Boston College.
With the addition of Mr. Hooley, the IDEXX Board of Directors now comprises ten directors, nine of whom are independent. This appointment underscores IDEXX’s commitment to fostering a diverse and experienced board that can effectively guide the company through its growth and innovation initiatives.
IDEXX Laboratories, Inc. is a global leader in pet healthcare innovation, offering diagnostic and software products and services that create clarity in the complex world of veterinary medicine. The company supports longer, fuller lives for pets by delivering insights and solutions that help the veterinary community make confident decisions. IDEXX's innovations also contribute to the safety of milk and water across the world and maintain the health and well-being of people and livestock.
IDEXX Laboratories, Inc. is a member of the S&P 500® Index and is headquartered in Maine, employing approximately 11,000 people and serving customers in more than 175 countries and territories.
References:
[1] https://www.stocktitan.net/news/IDXX/idexx-laboratories-elects-joseph-l-jay-hooley-to-board-of-m84b0hp9cpts.html
[2] https://finance.yahoo.com/news/idexx-laboratories-elects-joseph-l-110000623.html
Comments
No comments yet